Qualitative and quantitative expression status of the human chromosome 20 genes in cancer tissues and the representative cell lines

Journal of Proteome Research

Volumn 12, Issue 1, 2013, Pages 151-161

  Wang, Quanhui ^a,b,c   Wen, Bo ^b,c   Yan, Guangrong ^c,d   Wei, Junying ^c,e,f   Xie, Liqi ^c,e   Xu, Shaohang ^b   Jiang, Dahai ^b   Wang, Tingyou ^b   Lin, Liang ^b   Zi, Jin ^b   Zhang, Ju ^a   Zhou, Ruo ^b   Zhao, Haiyi ^b   Ren, Zhe ^b   Qu, Nengrong ^b   Lou, Xiaomin ^a   Sun, Haidan ^a   Du, Chaoqin ^b   Chen, Chuangbin ^b   Zhang, Shenyan ^a   Tan, Fengji ^b   Xian, Youqi ^b   Gao, Zhibo ^b   He, Minghui ^b   Chen, Longyun ^b   Zhao, Xiaohang ^e   Xu, Ping ^e,f   Zhu, Yunping ^e,f   Yin, Xingfeng ^d   Shen, Huali ^g   Zhang, Yang ^g   Jiang, Jing ^e,f   Zhang, Chengpu ^e,f   Li, Liwei ^e,f   Chang, Cheng ^e,f   Ma, Jie ^e,f   Yan, Guoquan ^g   Yao, Jun ^g   Lu, Haojie ^g   Ying, Wantao ^f   Zhong, Fan ^g   He, Qing Yu ^d   Liu, Siqi ^a,b   more..

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b BGI SHENZHEN   (China)

^c JINAN UNIVERSITY   (China)

^d BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^e National Engineering Research Center for Protein Drugs   (China)

^f FUDAN UNIVERSITY   (China)

^g CANCER HOSPITAL   (China)

Author keywords

C HPP; Chromosome; Chromosome features; Proteome; Quantitative correlations

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEOME;

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER TISSUE; CHROMOSOME 20; COLON CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STOMACH CANCER; TANDEM MASS SPECTROMETRY;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 20; COLON; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; LIVER; MASS SPECTROMETRY; NEOPLASMS; PROTEINS; PROTEOME; RNA, MESSENGER; STOMACH;

EID: 84874026295     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3008336     Document Type: Article

References (48)

1. Paik, Y. K.; Omenn, G. S.; Uhlen, M.; Hanash, S.; Marko-Varga, G.; Aebersold, R.; Bairoch, A.; Yamamoto, T.; Legrain, P.; Lee, H. J.; Na, K.; Jeong, S. K.; He, F.; Binz, P. A.; Nishimura, T.; Keown, P.; Baker, M. S.; Yoo, J. S.; Garin, J.; Archakov, A.; Bergeron, J.; Salekdeh, G. H.; Hancock, W. S. Standard guidelines for the Chromosome-centric Human Proteome Project. J. Proteome Res. 2012, 11 (4), 2005-13.
2. Paik, Y. K.; Jeong, S. K.; Omenn, G. S.; Uhlen, M.; Hanash, S.; Cho, S. Y.; Lee, H. J.; Na, K.; Choi, E. Y.; Yan, F.; Zhang, F.; Zhang, Y.; Snyder, M.; Cheng, Y.; Chen, R.; Marko-Varga, G.; Deutsch, E. W.; Kim, H.; Kwon, J. Y.; Aebersold, R.; Bairoch, A.; Taylor, A. D.; Kim, K. Y.; Lee, E. Y.; Hochstrasser, D.; Legrain, P.; Hancock, W. S. The Chromosomecentric Human Proteome Project for cataloging proteins encoded in the genome. Nat. Biotechnol. 2012, 30 (3), 221-3.
3. Deloukas, P.; Matthews, L. H.; Ashurst, J.; Burton, J.; Gilbert, J. G.; Jones, M.; Stavrides, G.; Almeida, J. P.; Babbage, A. K.; Bagguley, C. L.; Bailey, J.; Barlow, K. F.; Bates, K. N.; Beard, L. M.; Beare, D. M.; Beasley, O. P.; Bird, C. P.; Blakey, S. E.; Bridgeman, A. M.; Brown, A. J.; Buck, D.; Burrill, W.; Butler, A. P.; Carder, C.; Carter, N. P.; Chapman, J. C.; Clamp, M.; Clark, G.; Clark, L. N.; Clark, S. Y.; Clee, C. M.; Clegg, S.; Cobley, V. E.; Collier, R. E.; Connor, R.; Corby, N. R.; Coulson, A.; Coville, G. J.; Deadman, R.; Dhami, P.; Dunn, M.; Ellington, A. G.; Frankland, J. A.; Fraser, A.; French, L.; Garner, P.; Grafham, D. V.; Griffiths, C.; Griffiths, M. N.; Gwilliam, R.; Hall, R. E.; Hammond, S.; Harley, J. L.; Heath, P. D.; Ho, S.; Holden, J. L.; Howden, P. J.; Huckle, E.; Hunt, A. R.; Hunt, S. E.; Jekosch, K.; Johnson, C. M.; Johnson, D.; Kay, M. P.; Kimberley, A. M.; King, A.; Knights, A.; Laird, G. K.; Lawlor, S.; Lehvaslaiho, M. H.; Leversha, M.; Lloyd, C.; Lloyd, D. M.; Lovell, J. D.; Marsh, V. L.; Martin, S. L.; McConnachie, L. J.; McLay, K.; McMurray, A. A.; Milne, S.; Mistry, D.; Moore, M. J.; Mullikin, J. C.; Nickerson, T.; Oliver, K.; Parker, A.; Patel, R.; Pearce, T. A.; Peck, A. I.; Phillimore, B. J.; Prathalingam, S. R.; Plumb, R. W.; Ramsay, H.; Rice, C. M.; Ross, M. T.; Scott, C. E.; Sehra, H. K.; Shownkeen, R.; Sims, S.; Skuce, C. D.; Smith, M. L.; Soderlund, C.; Steward, C. A.; Sulston, J. E.; Swann, M.; Sycamore, N.; Taylor, R.; Tee, L.; Thomas, D. W.; Thorpe, A.; Tracey, A.; Tromans, A. C.; Vaudin, M.; Wall, M.; Wallis, J. M.; Whitehead, S. L.; Whittaker, P.; Willey, D. L.; Williams, L.; Williams, S. A.; Wilming, L.; Wray, P. W.; Hubbard, T.; Durbin, R. M.; Bentley, D. R.; Beck, S.; Rogers, J. The DNA sequence and comparative analysis of human chromosome 20. Nature 2001, 414 (6866), 865-71.
4. Buffart, T. E.; van Grieken, N. C.; Tijssen, M.; Coffa, J.; Ylstra, B.; Grabsch, H. I.; van de Velde, C. J.; Carvalho, B.; Meijer, G. A. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch. 2009, 455 (3), 213-23.
5. Davison, E. J.; Tarpey, P. S.; Fiegler, H.; Tomlinson, I. P.; Carter, N. P. Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization. Genes Chromosomes Cancer 2005, 44 (4), 384-91.
6. Hodgson, J. G.; Chin, K.; Collins, C.; Gray, J. W. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res. Treat. 2003, 78 (3), 337-45.
7. Karhu, R.; Mahlamaki, E.; Kallioniemi, A. Pancreatic adenocarcinoma- genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 2006, 45 (8), 721-30.
8. Alers, J. C.; Krijtenburg, P. J.; Vis, A. N.; Hoedemaeker, R. F.; Wildhagen, M. F.; Hop, W. C.; van Der Kwast, T. T.; Schroder, F. H.; Tanke, H. J.; van Dekken, H. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features. Am. J. Pathol. 2001, 158 (2), 399-406.
9. Tabach, Y.; Kogan-Sakin, I.; Buganim, Y.; Solomon, H.; Goldfinger, N.; Hovland, R.; Ke, X. S.; Oyan, A. M.; Kalland, K. H.; Rotter, V.; Domany, E. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS One 2011, 6 (1), e14632.
10. Behrens, P.; Brinkmann, U.; Wellmann, A. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 2003, 8 (1), 39-44.
11. Wellmann, A.; Flemming, P.; Behrens, P.; Wuppermann, K.; Lang, H.; Oldhafer, K.; Pastan, I.; Brinkmann, U. High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. Int. J. Mol. Med. 2001, 7 (5), 489-94.
12. Peng, Z.; Zhou, C.; Zhang, F.; Ling, Y.; Tang, H.; Bai, S.; Liu, W.; Qiu, G.; He, L. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer. Chin. Med. J. (Engl.) 2002, 115 (10), 1529-32.
13. Xie, T.; G, D. A.; Lamb, J. R.; Martin, E.; Wang, K.; Tejpar, S.; Delorenzi, M.; Bosman, F. T.; Roth, A. D.; Yan, P.; Bougel, S.; Di Narzo, A. F.; Popovici, V.; Budinska, E.; Mao, M.; Weinrich, S. L.; Rejto, P. A.; Hodgson, J. G. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. PLoS One 2012, 7 (7), e42001.
14. Legrain, P.; Aebersold, R.; Archakov, A.; Bairoch, A.; Bala, K.; Beretta, L.; Bergeron, J.; Borchers, C. H.; Corthals, G. L.; Costello, C. E.; Deutsch, E. W.; Domon, B.; Hancock, W.; He, F.; Hochstrasser, D.; Marko-Varga, G.; Salekdeh, G. H.; Sechi, S.; Snyder, M.; Srivastava, S.; Uhlen, M.; Wu, C. H.; Yamamoto, T.; Paik, Y. K.; Omenn, G. S. The human proteome project: current state and future direction. Mol. Cell. Proteomics 2011, 10 (7), M111 009993.
15. Geiger, T.; Wehner, A.; Schaab, C.; Cox, J.; Mann, M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell. Proteomics 2012, 11 (3), M111 014050.
16. Agaton, C.; Galli, J.; Hoiden Guthenberg, I.; Janzon, L.; Hansson, M.; Asplund, A.; Brundell, E.; Lindberg, S.; Ruthberg, I.; Wester, K.; Wurtz, D.; Hoog, C.; Lundeberg, J.; Stahl, S.; Ponten, F.; Uhlen, M. Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol. Cell. Proteomics 2003, 2 (6), 405-14.
17. Uhlen, M.; Oksvold, P.; Algenas, C.; Hamsten, C.; Fagerberg, L.; Klevebring, D.; Lundberg, E.; Odeberg, J.; Ponten, F.; Kondo, T.; Sivertsson, A. Antibody-based protein profiling of the human chromosome 21. Mol. Cell. Proteomics 2012, 11 (3), M111 013458.
18. Li, N.; Wu, S.; Zhang, C.; Chang, C.; Zhang, J.; Ma, J.; Li, L.; Qian, X.; Xu, P.; Zhu, Y.; He, F. PepDistiller: A quality control tool to improve the sensitivity and accuracy of peptide identifications in shotgun proteomics. Proteomics 2012, 12 (11), 1720-5.
19. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007, 4 (3), 207-14.
20. Schwanhausser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global quantification of mammalian gene expression control. Nature 2011, 473 (7347), 337-42.
21. Griffin, N. M.; Yu, J.; Long, F.; Oh, P.; Shore, S.; Li, Y.; Koziol, J. A.; Schnitzer, J. E. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol. 2010, 28 (1), 83-9.
22. Kim, Y. H.; Liang, H.; Liu, X.; Lee, J. S.; Cho, J. Y.; Cheong, J. H.; Kim, H.; Li, M.; Downey, T. J.; Dyer, M. D.; Sun, Y.; Sun, J.; Beasley, E. M.; Chung, H. C.; Noh, S. H.; Weinstein, J. N.; Liu, C. G.; Powis, G. AMPKalpha modulation in cancer progression: multilayer integrativeanalysis of the whole transcriptome in Asian gastric cancer. Cancer Res. 2012, 72 (10), 2512-21.
23. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487 (7407), 330-7.
24. Huang, Q.; Lin, B.; Liu, H.; Ma, X.; Mo, F.; Yu, W.; Li, L.; Li, H.; Tian, T.; Wu, D.; Shen, F.; Xing, J.; Chen, Z. N. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma. PLoS One 2011, 6 (10), e26168.
25. Mortazavi, A.; Williams, B. A.; McCue, K.; Schaeffer, L.; Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5 (7), 621-8.
26. Langfelder, P.; Horvath, S.; Fast, R. Functions for robust correlations and hierarchical clustering. J. Stat. Software 2012, 46, 11.
27. Krzywinski, M.; Schein, J.; Birol, I.; Connors, J.; Gascoyne, R.; Horsman, D.; Jones, S. J.; Marra, M. A. Circos: an information aesthetic for comparative genomics. Genome Res. 2009, 19 (9), 1639-45.
28. Kozomara, A.; Griffiths-Jones, S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39 (Database issue), D152-7.
29. Parra, G.; Bradnam, K.; Korf, I. CEGMA: a pipeline to accurately annotate core genes in eukaryotic genomes. Bioinformatics 2007, 23 (9), 1061-7.
30. Fox, J. Nonparametric simple regression: smoothing scatterplots; Sage: Thousand Oaks, London, 2000; p viii, 83.
31. de Hoon, M. J.; Imoto, S.; Nolan, J.; Miyano, S. Open source clustering software. Bioinformatics 2004, 20 (9), 1453-4.
32. Misumi, T.; Yamamoto, Y.; Miyachika, Y.; Eguchi, S.; Chochi, Y.; Nakao, M.; Nagao, K.; Hara, T.; Sakano, S.; Furuya, T.; Oga, A.; Kawauchi, S.; Sasaki, K.; Matsuyama, H. DNA copy number aberrations associated with lymphovascular invasion in upper urinary tract urothelial carcinoma. Cancer Genet. 2012, 205 (6), 313-8.
33. Vauhkonen, H.; Vauhkonen, M.; Sajantila, A.; Sipponen, P.; Knuutila, S. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization. Cancer Genet. Cytogenet. 2006, 167 (2), 150-4.
34. Huh, J.; Tiu, R. V.; Gondek, L. P.; O'Keefe, C. L.; Jasek, M.; Makishima, H.; Jankowska, A. M.; Jiang, Y.; Verma, A.; Theil, K. S.; McDevitt, M. A.; Maciejewski, J. P. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 2010, 49 (4), 390-9.
35. Akan, P.; Sahlen, M.; Deloukas, P. A histone map of human chromosome 20q13.12. PLoS One 2009, 4 (2), e4479.
36. Bench, A. J.; Nacheva, E. P.; Hood, T. L.; Holden, J. L.; French, L.; Swanton, S.; Champion, K. M.; Li, J.; Whittaker, P.; Stavrides, G.; Hunt, A. R.; Huntly, B. J.; Campbell, L. J.; Bentley, D. R.; Deloukas, P.; Green, A. R. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 2000, 19 (34), 3902-13.
37. Mackinnon, R. N.; Selan, C.; Wall, M.; Baker, E.; Nandurkar, H.; Campbell, L. J. The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion. Genes Chromosomes Cancer 2010, 49 (11), 998-1013.
38. Stuart, P. E.; Huffmeier, U.; Nair, R. P.; Palla, R.; Tejasvi, T.; Schalkwijk, J.; Elder, J. T.; Reis, A.; Armour, J. A. Association of betadefensin copy number and psoriasis in three cohorts of european origin. J. Invest. Dermatol. 2012, 132, 2407-13.
39. Toubar, R. A.; Zhmurov, A.; Barsegov, V.; Marx, K. A. Comparative simulation studies of native and single-site mutant human beta-defensin-1 peptides. J. Biomol. Struct. Dyn. 2012.
40. Rajaraman, P.; Melin, B. S.; Wang, Z.; McKean-Cowdin, R.; Michaud, D. S.; Wang, S. S.; Bondy, M.; Houlston, R.; Jenkins, R. B.; Wrensch, M.; Yeager, M.; Ahlbom, A.; Albanes, D.; Andersson, U.; Freeman, L. E.; Buring, J. E.; Butler, M. A.; Braganza, M.; Carreon, T.; Feychting, M.; Fleming, S. J.; Gapstur, S. M.; Gaziano, J. M.; Giles, G. G.; Hallmans, G.; Henriksson, R.; Hoffman-Bolton, J.; Inskip, P. D.; Johansen, C.; Kitahara, C. M.; Lathrop, M.; Liu, C.; Le Marchand, L.; Linet, M. S.; Lonn, S.; Peters, U.; Purdue, M. P.; Rothman, N.; Ruder, A. M.; Sanson, M.; Sesso, H. D.; Severi, G.; Shu, X. O.; Simon, M.; Stampfer, M.; Stevens, V. L.; Visvanathan, K.; White, E.; Wolk, A.; Zeleniuch-Jacquotte, A.; Zheng, W.; Decker, P.; Enciso-Mora, V.; Fridley, B.; Gao, Y. T.; Kosel, M.; Lachance, D. H.; Lau, C.; Rice, T.; Swerdlow, A.; Wiemels, J. L.; Wiencke, J. K.; Shete, S.; Xiang, Y. B.; Xiao, Y.; Hoover, R. N.; Fraumeni, J. F., Jr.; Chatterjee, N.; Hartge, P.; Chanock, S. J. Genome-wide association study of glioma and metaanalysis. Hum. Genet. 2012, 131 (12), 1877-88.
41. Houlston, R. S.; Cheadle, J.; Dobbins, S. E.; Tenesa, A.; Jones, A. M.; Howarth, K.; Spain, S. L.; Broderick, P.; Domingo, E.; Farrington, S.; Prendergast, J. G.; Pittman, A. M.; Theodoratou, E.; Smith, C. G.; Olver, B.; Walther, A.; Barnetson, R. A.; Churchman, M.; Jaeger, E. E.; Penegar, S.; Barclay, E.; Martin, L.; Gorman, M.; Mager, R.; Johnstone, E.; Midgley, R.; Niittymaki, I.; Tuupanen, S.; Colley, J.; Idziaszczyk, S.; Thomas, H. J.; Lucassen, A. M.; Evans, D. G.; Maher, E. R.; Maughan, T.; Dimas, A.; Dermitzakis, E.; Cazier, J. B.; Aaltonen, L. A.; Pharoah, P.; Kerr, D. J.; Carvajal-Carmona, L. G.; Campbell, H.; Dunlop, M. G.; Tomlinson, I. P. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet. 2010, 42 (11), 973-7.
42. Song, X.; Zhou, K.; Zhao, Y.; Huai, C.; Yu, H.; Chen, Y.; Chen, G.; Chen, H.; Fan, W.; Mao, Y.; Lu, D. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population. Carcinogenesis 2012, 33 (5), 1065-71.
43. Setia, S.; Sanyal, S. N. Downregulation of NF-kappaB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer. Mol. Cell. Biochem. 2012, 369 (1-2), 75-86.
44. Zhao, H.; Ho, P. C.; Lo, Y. H.; Espejo, A.; Bedford, M. T.; Hung, M. C.; Wang, S. C. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. PLoS One 2012, 7 (1), e29416.
45. Antonacopoulou, A. G.; Grivas, P. D.; Skarlas, L.; Kalofonos, M.; Scopa, C. D.; Kalofonos, H. P. POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Res. 2008, 28 (2B), 1221-7.
46. Antonacopoulou, A. G.; Palli, M.; Marousi, S.; Dimitrakopoulos, F. I.; Kyriakopoulou, U.; Tsamandas, A. C.; Scopa, C. D.; Papavassiliou, A. G.; Kalofonos, H. P. Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer. Mol. Carcinog. 2010, 49 (7), 693-9.
47. Nagaraj, N.; Wisniewski, J. R.; Geiger, T.; Cox, J.; Kircher, M.; Kelso, J.; Paabo, S.; Mann, M. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 2011, 7, 548.
48. Traylor, R. N.; Bruno, D. L.; Burgess, T.; Wildin, R.; Spencer, A.; Ganesamoorthy, D.; Amor, D. J.; Hunter, M.; Caplan, M.; Rosenfeld, J. A.; Theisen, A.; Torchia, B. S.; Shaffer, L. G.; Ballif, B. C.; Slater, H. R. A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33. PLoS One 2010, 5 (8), e12462.